Geron Corporation (LON:0IV3)
London · Delayed Price · Currency is GBP · Price in USD 1.455
+0.030 (2.11%)
At close: Aug 22, 2025
Geron Market Cap
Geron has a market cap or net worth of 688.05 million as of August 22, 2025. Its market cap has decreased by -67.64% in one year.
Market Cap
688.05M
Enterprise Value
459.89M
Revenue
120.03M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.46
Market Cap Chart
Since July 31, 1996, Geron's market cap has increased from 4.63M to 688.05M, an increase of 14,764.72%. That is a compound annual growth rate of 18.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 22, 2025 | 688.05M | -59.75% |
| Dec 31, 2024 | 1.71B | 90.01% |
| Dec 29, 2023 | 899.60M | 17.49% |
| Dec 30, 2022 | 765.70M | 163.97% |
| Dec 31, 2021 | 290.07M | -19.77% |
| Dec 31, 2020 | 361.57M | 76.25% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 185.59B |
| GSK plc | 59.62B |
| Haleon | 32.68B |
| Smith & Nephew | 12.05B |
| ConvaTec Group | 4.96B |
| Hikma Pharmaceuticals | 4.07B |
| HUTCHMED (China) | 2.03B |
| Oxford Nanopore Technologies | 2.00B |